Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized Placebo-Controlled Study of Fisetin and Exercise to Prevent Frailty in Breast Cancer Survivors

NCT06113016 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT06113016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06113016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized Placebo-Controlled Study of Fisetin and Exercise to Prevent Frailty in Breast Cancer Survivors
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
July 23, 2024
Completion date
October 31, 2031
Enrollment
164 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage i breast cancer american joint committee on cancer (ajcc) v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iii breast cancer ajcc v8, early stage breast carcinoma